Filing Details
- Accession Number:
- 0001209191-21-043707
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-29 17:26:57
- Reporting Period:
- 2021-06-28
- Accepted Time:
- 2021-06-29 17:26:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1662774 | Cortexyme Inc. | CRTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1770823 | Margaret Mcloughlin | C/O Cortexyme, Inc. 269 East Grand Ave. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-06-28 | 200 | $55.01 | 350 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-06-28 | 250 | $55.03 | 100 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-06-28 | 100 | $55.73 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2020.